Trial intelligence / Profile preview

Exenatide in Obese Women Without Diabetes

NCT00456885Phase 4Completed

Sponsor
Beth Israel Deaconess Medical Center
Start
Apr 2007
Primary completion
Sep 2010
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of exenatide in obesity, sponsored by Beth Israel Deaconess Medical Center. Started Apr 2007; status: completed.

02

Drugs

exenatide
03

Conditions

obesity

Beyond the preview

Go deeper on NCT00456885.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00456885.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call